Baseline Characteristics
| Baseline Characteristics | Intervention Group(n = 19) No. | Control Group(n = 19) No. |
|---|---|---|
| GERD = gastroesophageal reflux disease, COX-2 inhibitors = selective cyclooxygenase 2 inhibitors, NSAIDs = nonsteroidal anti-inflammatory drugs. | ||
| P >.1 for all baseline comparisons, except GERD medications (P = .04). | ||
| Member months | 91,542 | 92,094 |
| Number of patients treated with a new prescription | 3,305 | 3,307 |
| Number of new prescriptions | 5,920 | 5,920 |
| Number of new and refilled prescriptions | 13,347 | 13,533 |
| Number of patients with a new prescription from the high-cost drug categories | No. (%) | No. (%) |
| Antibiotics | 923 (28) | 954 (29) |
| Antidepressants | 369 (11) | 367 (11) |
| Rhinitis medications | 334 (10) | 346 (11) |
| GERD medications | 253 (8) | 189 (6) |
| Asthma medications | 262 (8) | 218 (7) |
| Diabetes medications | 154 (5) | 177 (5) |
| Antihypertension medications, diuretics | 393 (12) | 411 (12) |
| Lipid-lowering therapies | 150 (5) | 204 (6) |
| Triptans and headache medications | 91 (3) | 79 (2) |
| COX-2 inhibitors and NSAIDs | 385 (12) | 277 (8) |
| Total | 2,496 (76) | 2,434 (74) |